John J McGrath
John J McGrath
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,✉,
Sukanta Saha
Sukanta Saha
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Carmen C W Lim
Carmen C W Lim
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Sergio Aguilar-Gaxiola
Sergio Aguilar-Gaxiola
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Jordi Alonso
Jordi Alonso
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Laura H Andrade
Laura H Andrade
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Evelyn J Bromet
Evelyn J Bromet
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Ronny Bruffaerts
Ronny Bruffaerts
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
José M Caldas de Almeida
José M Caldas de Almeida
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Graça Cardoso
Graça Cardoso
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Giovanni de Girolamo
Giovanni de Girolamo
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
John Fayyad
John Fayyad
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Silvia Florescu
Silvia Florescu
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Oye Gureje
Oye Gureje
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Josep M Haro
Josep M Haro
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Norito Kawakami
Norito Kawakami
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Karestan C Koenen
Karestan C Koenen
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Viviane Kovess-Masfety
Viviane Kovess-Masfety
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Sing Lee
Sing Lee
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Jean-Pierre Lepine
Jean-Pierre Lepine
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Katie A McLaughlin
Katie A McLaughlin
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Maria E Medina-Mora
Maria E Medina-Mora
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Fernando Navarro-Mateu
Fernando Navarro-Mateu
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Akin Ojagbemi
Akin Ojagbemi
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Jose Posada-Villa
Jose Posada-Villa
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Nancy Sampson
Nancy Sampson
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Kate M Scott
Kate M Scott
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Hisateru Tachimori
Hisateru Tachimori
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Margreet ten Have
Margreet ten Have
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Kenneth S Kendler
Kenneth S Kendler
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1,
Ronald C Kessler
Ronald C Kessler
1John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology – LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum – Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) – St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
1;
on behalf of the WHO World Mental Health Survey Collaborators1,*